A Maine family planning clinic launched a program to reach women who experience barriers to reproductive healthcare, counseling, and testing for sexually transmitted infections. The program focused on outreach, sending an educator to various locations and providing an educational session for women who are especially vulnerable, including those who use opioids.

Latina-identified immigrants experience multiple barriers to healthcare, including contraception and reproductive care. This can result in lack of access to affordable preventive screenings, such as Pap smears, mammograms, and tests for sexually transmitted infections, according to the authors of a recent study.

According to the statement, human embryo research is ethically acceptable if it is “likely to provide significant new knowledge that may benefit human health, well-being of the offspring, or reproduction.”

The authors of a recent study found that Black women in the United States have a lower risk of giving birth to low birth weight babies if they live in states with less restrictive reproductive rights, when compared with women who live in states with more restrictive policies.

Women who receive treatment for a substance use disorder would welcome services that integrate their treatment with family planning and contraceptive services, the authors of a recent study found.

OB/GYNs and family planning clinicians should screen all patients for substance use disorders, as recommended by researchers and professional guidelines. Recent guidelines from the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice recommend anyone who enters a physician’s office for reproductive health services receive a screening for a substance use disorder.

Essential Access Health and other family planning advocacy organizations petitioned the Supreme Court to review a Court of Appeals decision that upholds the Trump administration’s Title X regulations and gag rule. Because of the changes, the number of Title X sites in California dropped from 366 to 238.

Martha Brady, MS, director of sexual and reproductive health for PATH in Washington, DC, spoke to Contraceptive Technology Update about reproductive health self-care and how it works in other nations.

A new study revealed that women can engage in self-care reproductive health through the use of subcutaneous injectable contraception. Adherence has long been a barrier to using injectable contraceptives. Could women administer the medication at the correct time and in the correct way? The authors of a new study answer that question affirmatively.